HenryG.KaplanMD

PubMed

• Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
  Elias, A., Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, A Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M Wallace, Henry Kapla...> ;Clinical Cancer Research. 2024 Feb 16
• 1 citations
  Cobimetinib Plus Vemurafenib in Patients With Solid Tumors WithMutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
  Meric-Bernstam, F., Rothe, M., Mangat, P., Garrett-Mayer, E., Gutierrez, R., Ahn, E., Cannon, T., Powell, S., Krauss, J., Reynolds, C., von Mehren, M., Behl, D., Calfa...> ;JCO Precision Oncology. 2023 Sep 1
• 2 citations
  Epidemiology of interstitial lung disease in patients with metastatic breast cancer at baseline and after treatment with HER2-directed therapy: a real-world data analy...
  Jeanna Wallenta Law, Alicyn Campbell, Colin Weller, Colden Johanson, Ronda Broome, Elisabeth Piault, Monika Izano, Andrew Schrag, Mary Tran, Thomas D Brown, Henry G Ka...> ;Breast Cancer Research and Treatment. 2022 Dec 1
• 2 citations
  Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999-2018.
  Henry G Kaplan, Judith A Malmgren, Boya Guo, Mary K Atwood> ;Breast Cancer Research and Treatment. 2022 Sep 1
• 7 citations
  PCM1-JAK2 Fusion Tyrosine Kinase Gene-Related Neoplasia: A Systematic Review of the Clinical Literature.
  Henry G Kaplan, Ruyun Jin, Carlo B Bifulco, James M Scanlan, David R Corwin> ;The Oncologist. 2022 Aug 5
• 7 citations
  Response of Leptomeningeal Metastasis of Breast Cancer With a HER2/neu Activating Variant to Tucatinib: A Case Report.
  Fengting Yan, Kristine J Rinn, Jonathon A Kullnat, Aimee Y Wu, Maura D Ennett, Elizabeth L Scott, Henry G Kaplan> ;Journal of the National Comprehensive Cancer Network. 2022 Apr 11
• 3 citations
  Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysi...
  Jeanna Wallenta Law, Debanjali Mitra, Henry G Kaplan, Tamuno Alfred, Adam M Brufsky, Birol Emir, Haley McCracken, Xianchen Liu, Ronda G Broome, Chenan Zhang, Caroline ...> ;Current Oncology. 2022 Feb 12
• 9 citations
  Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection.
  , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Plos One. 2021 Nov 17
• 13 citations
  Continued proportional age shift of confirmed positive COVID-19 incidence over time to children and young adults: Washington State March-August 2020.
  Judith A. Malmgren, Henry G. Kaplan> ;Plos One. 2021 Mar 24
• 3 citations
  Breast cancer distant recurrence lead time interval by detection method in an institutional cohort
  Henry G. Kaplan, Judith A. Malmgren, Mary Atwood> ;BMC Cancer. 2020 Nov 20
• 10 citations
  Maximizing Breast Cancer Therapy with Awareness of Potential Treatment-Related Blood Disorders
  Henry G. Kaplan, Gregory S. Calip, Judith A. Malmgren> ;The Oncologist. 2020 May 1
• 18 citations
  Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
  Judith A. Malmgren, Gregory S. Calip, MK Atwood, Henry G. Kaplan> ;Cancer. 2020 Jan 15
• Granulocyte Colony-Stimulating Factors in Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia.
  Henry G. Kaplan, Judith A. Malmgren, Gregory S. Calip> ;JAMA Oncology. 2019 Jul 1
• 18 citations
  Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990-2011.
  Judith A. Malmgren, Marc Hurlbert, Henry G. Kaplan> ;Breast Cancer Research and Treatment. 2019 Apr 1
• 11 citations
  Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients
  Saul E. Rivkin, James Moon, Desiree Iriarte, Erik Bailey, Heather L. Sloan, Gary E. Goodman, Amy E. Bondurant, Dan Velijovich, Tanya A. Wahl, Peter Jiang, Chirag A. Sh...> ;International Journal of Gynecological Cancer. 2019 Jan 29
• Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
  Boughey, J. C.,Alvarado, M. D.,Lancaster, R. B.,Symmans, W. F.,Mukhtar, R.,Wong, J. M.,Ewing, C. A.,Potter, D. A.,Tuttle, T. M.,Hieken, T. J.,Carter, J. M.,Jakub, J. W...> ;NPJ Breast Cancer. 2019 Jan 25
• Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
  Boughey, J. C.,Alvarado, M. D.,Lancaster, R. B.,Fraser Symmans, W.,Mukhtar, R.,Wong, J. M.,Ewing, C. A.,Potter, D. A.,Tuttle, T. M.,Hieken, T. J.,Carter, J. M.,Jakub, ...> ;NPJ Breast Cancer. 2018 Aug 23
• 10 citations
  Pharmacokinetics of dacarbazine (DTIC) in pregnancy
  Ira Kantrowitz-Gordon, Karen Hays, Olumide Kayode, Henry G. Kaplan, Joel M. Reid, Stephanie L. Safgren, Matthew M. Ames, Thomas R. Easterling, Mary F. Hebert> ;Cancer Chemotherapy and Pharmacology. 2018 Jan 5
• 94 citations
  Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990–2010
  Judith A. Malmgren, Musa Mayer, Henry G. Kaplan> ;Breast Cancer Research and Treatment. 2018 Jan 1
• 25 citations
  Triple-negative breast cancer in the elderly: Prognosis and treatment.
  Henry G. Kaplan, Judith A. Malmgren, Mary Atwood> ;The Breast Journal. 2017 May 9
• 12 citations
  Therapy-related myelodysplastic syndrome following primary breast cancer
  Judith A. Malmgren, Gregory S. Calip, Shawna M. Pyott, Henry G. Kaplan> ;Leukemia Research. 2016 Aug 1
• Adaptive Randomization of Neratinib in Early Breast Cancer.
  Park JW, Liu MC, Yee D, Yau C, van 't Veer LJ, Symmans WF, Paoloni M, Perlmutter J, Hylton NM, Hogarth M, DeMichele A, Buxton MB, Chien AJ, Wallace AM, Boughey JC, Had...> ;N. Engl. J. Med.. 2016-07-07
• 393 citations
  Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer
  Hope S. Rugo, Olufunmilayo I. Olopade, Angela DeMichele, Christina Yau, Laura J. van't Veer, Meredith Buxton, Michael Hogarth, Nola M. Hylton, Melissa Paoloni, Jane Pe...> ;The New England Journal of Medicine. 2016 Jul 6
• 15 citations
  Identification of BRAF Kinase Domain Duplications Across Multiple Tumor Types and Response to RAF Inhibitor Therapy.
  Samuel J. Klempner, Rodolfo Bordoni, Kyle Gowen, Henry G. Kaplan, Philip J. Stephens, Sai-Hong Ignatius Ou, Siraj M. Ali> ;JAMA Oncology. 2016 Feb 1
• 23 citations
  Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer.
  Gregory S. Calip, Judith A. Malmgren, Wan Ju Lee, Henry G. Kaplan> ;Breast Cancer Research and Treatment. 2015 Oct 8
• Join now to see all